Prostate and metastasis diffusion volume based on apparent diffusion coefficient as a prognostic factor in Hormone-naïve prostate Cancer-Reference-Cited by-同舟云学术

Prostate and metastasis diffusion volume based on apparent diffusion coefficient as a prognostic factor in Hormone-naïve prostate Cancer

Published:2023-03-14 Issue:2 Volume:40 Page:187-195
ISSN:0262-0898
Container-title:Clinical & Experimental Metastasis
language:en
Short-container-title:Clin Exp Metastasis

Author:

Fujiwara Motohiro,Yoshida Soichiro,Takahara Taro,Soma Takahiko,Nakamura Yuki,Ishikawa Yudai,Fukuda Shohei,Waseda Yuma,Tanaka Hajime,Yokoyama Minato,Fujii Yasuhisa

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10585-023-10200-2.pdf

Reference17 articles.

1. Kyriakopoulos CE, Chen YH, Carducci MA, Liu G, Jarrard DF, Hahn NM, Shevrin DH et al (2018) Chemohormonal therapy in metastatic hormone-sensitive prostate cancer: long-term survival analysis of the randomized phase III E3805 CHAARTED trial. J Clin Oncol 36(11):1080–1087. https://doi.org/10.1200/JCO.2017.75.3657

2. Fizazi K, Tran NP, Fein L, Matsubara N, Rodriguez-Antolin A, Alekseev BY, Özgüroğlu M et al (2019) Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial. Lancet Oncol 20(5):686–700. https://doi.org/10.1016/S1470-2045(19)30082-8

3. Trabulsi EJ, Rumble RB, Jadvar H, Hope T, Pomper M, Turkbey B, Rosenkrantz AB et al (2020) Optimum imaging strategies for advanced prostate cancer: ASCO guideline. J Clin Oncol 38(17):1963–1996. https://doi.org/10.1200/JCO.19.02757

4. Perera M, Papa N, Christidis D, Wetherell D, Hofman MS, Murphy DG, Bolton D et al (2016) Sensitivity, specificity, and predictors of positive 68Ga–prostate-specific membrane antigen positron emission tomography in advanced prostate cancer: a systematic review and meta-analysis. Eur Urol 70(6):926–937. https://doi.org/10.1016/j.eururo.2016.06.021

5. Padhani AR, Lecouvet FE, Tunariu N, Koh DM, De Keyzer F, Collins DJ, Sala E et al (2017) METastasis reporting and data system for prostate cancer: practical guidelines for acquisition, interpretation, and reporting of whole-body magnetic resonance imaging-based evaluations of multiorgan involvement in advanced prostate cancer. Eur Urol 71(1):81–92. https://doi.org/10.1016/j.eururo.2016.05.033

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The STAMPEDE2 Trial: a Site Survey of Current Patterns of Care, Access to Imaging and Treatment of Metastatic Prostate Cancer;Clinical Oncology;2023-10